# LOTEPREDNOL ETABONATE
> **ANDA207609** · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2019-04-17
## Drug
- **FDA Application Number:** ANDA207609
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOTEPREDNOL ETABONATE
- **Generic name:** LOTEPREDNOL ETABONATE
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** SENTISS
- **Manufacturer:** Sentiss Pharmaceuticals LLC
- **First approval:** 2019-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207609)
---
*AI Analytics · CC0 1.0*